Abbott Laboratories is Shariah compliant. The company passes all five major Shariah standards.
ABT – Abbott Laboratories
Compliant
★★★★★
- Medical Equipment, Supplies & Distribution
- NYSE
- July 16, 2022
$200,552,929,782
Market cap
80.34%
Revenue Growth
BUY
Analysts' Rating
AAOIFI
S&P
DJIM
FTSE
MSCI
AAOIFI
AAOIFI ✓
Debt ÷ Market cap (MC) | 9% | ✓ |
Non-Compliant Assets ÷ MC | 0.22% | ✓ |
Impure Income (incl. Interest) | 0.1% | ✓ |
Impure Income | % |
Interest Income | 0.1% |
Total | 0.1% |
S&P
S&P ✓
Debt ÷ 36 mo MC | 9.75% | ✓ |
Cash ÷ 36 mo MC | 5.29% | ✓ |
AR ÷ 36 mo MC | 3.79% | ✓ |
DJIM
DJIM ✓
Debt ÷ 24 mo MC | 8.79% | ✓ |
Cash ÷ 24 mo MC | 4.77% | ✓ |
AR ÷ 24 mo MC | 3.41% | ✓ |
FTSE
FTSE ✓
Debt ÷ Assets | 24% | ✓ |
Cash ÷ Assets | 13.03% | ✓ |
Cash&AR ÷ Assets | 22.35% | ✓ |
Impure Income (incl. Interest) | 0.1% | ✓ |
Impure Income | % |
Interest Income | 0.1% |
Total | 0.1% |
MSCI
MSCI ✓
Debt ÷ Assets | 24% | ✓ |
Cash ÷ Assets | 13.03% | ✓ |
Cash&AR ÷ Assets | 22.35% | ✓ |
Recommendation Rating
1.87
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Analysts’ Price Targets
Mean 141.7
Low: 111
High: 158.5
Total Analysts: 23
Company Profile
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.
Responses